Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study. (June 2021) - Saxena, Aaruni; Karim, Syed; Shafiq, Tahir; Umar, Sumbal; Ho, Michael; Khan, Sarah